IMMUNOCORE HLDGS PLC's ticker is IMCR and the CUSIP is 45258D105. A total of 123 filers reported holding IMMUNOCORE HLDGS PLC in Q2 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,050,640 | -13.4% | 405,600 | 0.0% | 2.97% | -17.0% |
| Q2 2023 | $24,319,776 | +21.3% | 405,600 | 0.0% | 3.58% | +19.8% |
| Q1 2023 | $20,052,864 | -13.4% | 405,600 | 0.0% | 2.99% | -11.2% |
| Q4 2022 | $23,147,592 | +21.6% | 405,600 | 0.0% | 3.36% | +44.0% |
| Q3 2022 | $19,039,000 | +32.3% | 405,600 | +5.2% | 2.34% | +7.0% |
| Q2 2022 | $14,387,000 | +24.8% | 385,600 | 0.0% | 2.18% | -5.3% |
| Q1 2022 | $11,529,000 | – | 385,600 | – | 2.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 576,923 | $21,400,000 | 6.26% |
| Rock Springs Capital Management LP | 2,445,155 | $90,642,000 | 1.91% |
| Avidity Partners Management LP | 1,095,600 | $40,614,000 | 0.90% |
| Bain Capital Public Equity Management II, LLC | 638,205 | $23,658,000 | 0.83% |
| RTW INVESTMENTS, LP | 1,245,532 | $46,172,000 | 0.70% |
| Baker Brothers Advisors | 2,520,730 | $93,443,000 | 0.41% |
| Samsara BioCapital, LLC | 64,000 | $2,372,000 | 0.37% |
| Pier Capital, LLC | 78,514 | $2,911,000 | 0.30% |
| Rhenman & Partners Asset Management AB | 90,000 | $3,336,000 | 0.23% |
| Perceptive Advisors | 400,000 | $14,828,000 | 0.22% |